Skip Navigation


International Immunology Advance Access originally published online on September 17, 2009
International Immunology 2009 21(11):1263-1268; doi:10.1093/intimm/dxp092
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
21/11/1263    most recent
dxp092v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rajasekaran, N.
Right arrow Articles by Illges, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajasekaran, N.
Right arrow Articles by Illges, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2009. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Histidine decarboxylase but not histamine receptor 1 or 2 deficiency protects from K/BxN serum-induced arthritis

Narendiran Rajasekaran1,6, Samuel Solomon2, Takeshi Watanabe3, Hiroshi Ohtsu4, Mieczyslaw Gajda5, Rolf Bräuer5 and Harald Illges1

1 Immunology and Cell Biology, University of Applied Sciences Bonn-Rhein-Sieg, von-Liebig-Strasse 20, D-53359 Rheinbach, Germany
2 The Biomedical Research Centre, University of British Columbia, 2222 Health Sciences Mall, Vancouver, BCV6T 1Z3, Canada
3 Department of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan
4 Graduate School of Engineering, Applied Quantum Medical Engineering, Tohoku University, Aza-Aoba 6-6-01, Aramaki, Aoba-ku, Sendai, 980-8579, Japan
5 Institute of Pathology, University Hospital Jena, Ziegelmühlenweg 1, D-07740 Jena, Germany
6 Present address: Department of Pediatrics, Stanford University, Stanford, CA 94305, USA

Correspondence to: H. Illges; E-mail: harald.illges{at}fh-brs.de

Serum transfer from arthritic K/BxN mice into naive animals results in arthritis. Mast cells have been shown to be essential since mice lacking these cell type do not develop arthritis upon serum injection. Mast cell function depends on the release of granules filled with mediators such as histamine. Mice deficient in histidine decarboxylase (HDC–/–) that do not produce histamine and mice deficient for histamine receptor 1 (H1R–/–) or histamine receptor 2 (H2R–/–) were injected with arthritogenic sera from the K/BxN mice, and the progression of arthritis was observed through the next 2 weeks. HDC–/– mice that are histamine free developed a milder form of arthritis in comparison with the wild-type controls. In both receptor-deficient mice as well as in wild-type controls, the onset and severity of clinical arthritis and ankle thickening occurred during day 1 to 3. These results indicate that histamine is required but not indispensable for the development of serum-induced arthritis and histamine receptors other than those studied here may be involved.

Keywords: histamine receptor, histidine decarboxylase, K/BxN mouse model


Transmitting editor: A. Radbruch

Received 16 April 2009, accepted 19 August 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.